Parkinson's disease: a rethink of rodent models.

Experimental Brain Research
Heather L MelroseMatthew James Farrer

Abstract

Parkinson's disease (PD) is a multifactorial disease with a complex etiology that results from genetic risk factors, environmental exposures and most likely a combination of both. Rodent models of parkinsonism aim to reproduce key pathogenic features of the syndrome including movement disorder induced by the progressive loss of dopaminergic neurons in the substantia nigra, accompanied by the formation of alpha-synuclein containing Lewy body inclusions. Despite the creation of many excellent models, both chemically induced and genetically engineered, there is none that accurately demonstrates these features. Recent pathological staging studies in man have also emphasized the significant non-CNS component of PD that has yet to be tackled. Herein, we summarize rodent models of PD and what they offer to the field, and suggest future challenges and opportunities.

References

Jan 1, 1988·Annual Review of Neuroscience·I J Kopin, S P Markey
Jun 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·B S JeonR E Burke
Oct 3, 1998·The Journal of Biological Chemistry·P H JensenM Goedert
Dec 2, 2000·Nature Neuroscience·R BetarbetJ T Greenamyre
Dec 13, 2000·Experimental Gerontology·B SommerM A Ruegg
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·E MasliahL Mucke
Oct 10, 2001·BMC Neuroscience·C G Specht, R Schoepfer
Oct 30, 2001·Behavioural Brain Research·M SedelisJ P Huston
Nov 15, 2001·The Journal of Biological Chemistry·Amy B Manning-BogDonato A Di Monte
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Deniz KirikAnders Bjorklund
May 16, 2002·Experimental Neurology·Eric K RichfieldHoward J Federoff
Jun 27, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michael K LeeDon L Price
Jul 13, 2002·American Journal of Medical Genetics·Andrew WestUNKNOWN French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility on Parkinson's Disease
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·C Lo BiancoP Aebischer
Aug 30, 2002·Neurotoxicology and Teratology·Samuel G Speciale
Sep 24, 2002·Brain : a Journal of Neurology·Naheed L KhanPaola Piccini
Oct 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·William DauerRene Hen
Jan 9, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Dominique TwelvesCarl Counsell
Feb 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Deniz KirikAnders Björklund
May 23, 2003·The Journal of Biological Chemistry·Xiao Tao, Liang Tong
May 29, 2003·Neurology·S LincolnM Farrer
Jul 9, 2003·Annals of the New York Academy of Sciences·Stanley Fahn
Jul 16, 2003·Journal of Neurochemistry·Cathy AndorferPeter Davies
Aug 14, 2003·Human Molecular Genetics·Jean-Michel ItierJusto Garcia de Yebenes
Aug 22, 2003·The Journal of Biological Chemistry·Matthew S GoldbergJie Shen
Oct 24, 2003·Molecular and Cellular Neurosciences·Suzana GispertRobert L Nussbaum
Nov 5, 2003·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·V BonifatiP Heutink
Jan 27, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Paul J LockhartMatthew J Farrer
Feb 21, 2004·Human Molecular Genetics·Ignacio F MataMatthew J Farrer
Mar 12, 2004·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Diego LorenzettiMonica Justice

❮ Previous
Next ❯

Citations

Nov 13, 2008·Journal of Neural Transmission·Irina GurevicieneHeikki Tanila
Nov 19, 2008·Parkinsonism & Related Disorders·Christopher A Ross, Wanli W Smith
Jun 30, 2012·Cell Death and Differentiation·G Ashrafi, T L Schwarz
Dec 15, 2010·Nature Reviews. Drug Discovery·Lynn BedfordJames E Brownell
Dec 27, 2007·Acta Pharmacologica Sinica·Serena RosnerAvi Orr-Urtreger
Oct 13, 2010·Journal of Geriatric Psychiatry and Neurology·Lynn M BekrisCyrus P Zabetian
May 27, 2014·Longevity & Healthspan·Dao-Fu DaiPeter S Rabinovitch
Jul 7, 2012·Cellular and Molecular Life Sciences : CMLS·Franz MarxreiterJürgen Winkler
Aug 20, 2015·International Journal of Molecular Sciences·Jaime M RossGiuseppe Coppotelli
May 12, 2009·Neuroscience Letters·Zhen-Yun YuanMing-Wei Wang
Nov 4, 2008·Neuroscience Letters·Jing LiuMing-Wei Wang
May 13, 2008·Trends in Neurosciences·W Michael CaudleGary W Miller
Mar 28, 2007·Human Mutation·Eng-King Tan, Lisa M Skipper
May 1, 2008·Proteomics. Clinical Applications·Frank GillardonBastian Hengerer
May 23, 2007·The Mount Sinai Journal of Medicine, New York·Karl Kieburtz, C Warren Olanow
Jan 5, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·C Warren Olanow
Feb 19, 2008·The FEBS Journal·Mügen Terzioglu, Dagmar Galter
Mar 30, 2011·Annals of Neurology·Ari E BermanRaymond A Swanson
May 30, 2012·Journal of Neurochemistry·George StoicaIan Murray
Jul 26, 2012·Oxidative Medicine and Cellular Longevity·Mustafa VarçinSophie Sarre
Nov 28, 2013·Biochimica Et Biophysica Acta·Silvia CampelloFrancesco Cecconi
May 18, 2010·Biochimica Et Biophysica Acta·Yannic WaerzeggersAndreas H Jacobs
Nov 21, 2007·Expert Opinion on Therapeutic Targets·Konstanze F Winklhofer
Nov 6, 2012·Brain Research Bulletin·Tomás Lopes da FonsecaTiago Fleming Outeiro
Feb 11, 2010·Journal of Neuroscience Methods·Matthew P Yeager, Randolph A Coleman
Jul 23, 2013·European Journal of Pharmacology·Simone A van den BergeElly M Hol
Oct 24, 2007·Experimental Neurology·Marie-Francoise Chesselet
Nov 15, 2008·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry· Weidong LeJoseph Jankovic
Jun 23, 2020·Protein Science : a Publication of the Protein Society·Jacques FantiniNouara Yahi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics
Sheila M FlemingMarie-Francoise Chesselet
NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics
Jordi BovéSerge Przedborski
Behavioural Pharmacology
Sheila M Fleming, Marie-Francoise Chesselet
© 2022 Meta ULC. All rights reserved